Understanding Important Differences in Cancer Quality of Life Scores
Author Information
Author(s): A. Simon Pickard, Maureen P. Neary, David Cella
Primary Institution: Center for Pharmacoeconomic Research, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago
Hypothesis
The study aims to provide a range of estimates of minimally important differences (MIDs) in EQ-5D scores in cancer and to determine if estimates are comparable in lung cancer.
Conclusion
Important differences in EQ-5D utility and VAS scores were similar for all cancers and lung cancer, with the lower end of the range of estimates closer to the MID.
Supporting Evidence
- MIDs for EQ-5D UK-based utility scores ranged from 0.08 to 0.16.
- MIDs for US-based scores ranged from 0.06 to 0.12.
- The study found that MIDs for overall cancer and lung cancer cohorts were similar.
Takeaway
This study looked at how much change in health scores is important for cancer patients, finding that small changes can mean a lot.
Methodology
A retrospective analysis was conducted on cross-sectional data collected from 534 cancer patients using both anchor-based and distribution-based approaches.
Limitations
The sample size for lung cancer subgroups was small, which may affect the reliability of estimates.
Participant Demographics
Participants included 534 cancer patients with various types of cancer, including 50 lung cancer patients, with efforts made to balance gender representation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website